TREATMENT OF SHORT BOWEL SYNDROME PATIENTS WITH COLON-IN-CONTINUITY
First Claim
Patent Images
1. A method for treating a patient with short bowel syndrome presenting with colon-in-continuity with remnant small intestine, said method comprising administering to the patient h(Gly2)GLP-2 using a dosing regimen effective to enhance intestinal absorption by the patient.
4 Assignments
0 Petitions
Accused Products
Abstract
Intestinal absorption is enhanced in short bowel syndrome patients presenting with colon-in-continuity by treatment with a GLP-2 receptor agonist, such as teduglutide.
3 Citations
22 Claims
- 1. A method for treating a patient with short bowel syndrome presenting with colon-in-continuity with remnant small intestine, said method comprising administering to the patient h(Gly2)GLP-2 using a dosing regimen effective to enhance intestinal absorption by the patient.
-
10. A method for treating a patient with short bowel syndrome presenting with colon-in-continuity with remnant small intestine, said method comprising administering to the patient h(Gly2)GLP-2 using a dosing regimen effective to enhance intestinal absorption by the patient;
- wherein the h(Gly2)GLP-2 is administered daily at a dose of from 30 to 150 μ
g/kg by subcutaneous injection into the abdomen, thigh, or arm of said patient. - View Dependent Claims (11, 12, 17, 19)
- wherein the h(Gly2)GLP-2 is administered daily at a dose of from 30 to 150 μ
- 13. A method for treating a patient with short bowel syndrome who is dependent on parenteral nutrition and is presenting with colon-in-continuity with remnant small intestine, said method comprising administering to the patient h(Gly2)GLP-2 using a dosing regimen effective to enhance intestinal absorption by the patient.
Specification